These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Quantitative aspects on mitochondrial monoamine oxidase in human platelets. Wiberg A; Oreland L Med Biol; 1976 Apr; 54(2):137-41. PubMed ID: 1271873 [TBL] [Abstract][Full Text] [Related]
25. Platelet monoamine oxidase in schizophrenia with beta-phenylethylamine and benzylamine as substrates. Baron M; Perumal AS; Levitt M; Cannova G Biol Psychiatry; 1982 Apr; 17(4):479-83. PubMed ID: 7082713 [No Abstract] [Full Text] [Related]
26. Diminished activity of platelet monoamine oxidase in Down's syndrome. Benson PF; Southgate J Am J Hum Genet; 1971 Mar; 23(2):211-4. PubMed ID: 4253914 [No Abstract] [Full Text] [Related]
27. Platelet monoamine oxidase and the growth hormone response to apomorphine in schizophrenia. Malas KL; van Kammen DP; deFraites EA; Brown GM; Gold PW Biol Psychiatry; 1983 Feb; 18(2):255-9. PubMed ID: 6830934 [No Abstract] [Full Text] [Related]
28. Monoamine oxidase activity in blood platelets from autistic children. Takahashi S; Kanai H; Miyamoto Y Folia Psychiatr Neurol Jpn; 1977; 31(4):597-603. PubMed ID: 608661 [TBL] [Abstract][Full Text] [Related]
29. Neurotransmitter systems and personality measurements: a study in psychosomatic patients and healthy subjects. Arqué JM; Unzeta M; Torrubia R Neuropsychobiology; 1988; 19(3):149-57. PubMed ID: 2904661 [TBL] [Abstract][Full Text] [Related]
30. Platelet monoamine oxidase activity in diabetics. Azevedo M; Fernandes F; Lisboa P; Manso C Acta Med Port; 1980; 2(5-6):369-76. PubMed ID: 7293813 [No Abstract] [Full Text] [Related]